Literature DB >> 24813748

Advanced diagnostic imaging in privately insured patients: recent trends in utilization and payments.

Michal Horný1, James F Burgess2, Jedediah Horwitt3, Alan B Cohen3.   

Abstract

Recent studies have reported that the rate of growth in utilization of noninvasive diagnostic imaging has slowed, with a concomitant reduction in total payments to providers in the Medicare Part B fee-for-service population. Utilization and payment growth trends in commercially insured populations, however, are not as well understood. We used the Truven Health Analytics MarketScan® Commercial Claims and Encounters database containing more than 29 million individuals to investigate commercially insured population trends in utilization of and payments for CT, MRI, PET, and ultrasound procedures in the years 2007-2011. We found that imaging use--after a brief downturn in 2010--rose again in 2011, coupled with substantial increases in adjusted payments for all four imaging modalities, raising concerns about future efforts to stem growth in imaging use and associated spending.
Copyright © 2014 American College of Radiology. All rights reserved.

Entities:  

Keywords:  Diagnostic imaging; commercial insurance; payments; utilization

Mesh:

Year:  2014        PMID: 24813748     DOI: 10.1016/j.jacr.2014.01.019

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  2 in total

1.  Using Medical Claims for Policy Effectiveness Surveillance: Reimbursement and Utilization of Abdomen/Pelvis Computed Tomography Scans.

Authors:  Michal Horný; Jake R Morgan; Vanessa L Merker
Journal:  Health Serv Res       Date:  2015-03-09       Impact factor: 3.402

2.  Trends in Use of Medical Imaging in US Health Care Systems and in Ontario, Canada, 2000-2016.

Authors:  Rebecca Smith-Bindman; Marilyn L Kwan; Emily C Marlow; Mary Kay Theis; Wesley Bolch; Stephanie Y Cheng; Erin J A Bowles; James R Duncan; Robert T Greenlee; Lawrence H Kushi; Jason D Pole; Alanna K Rahm; Natasha K Stout; Sheila Weinmann; Diana L Miglioretti
Journal:  JAMA       Date:  2019-09-03       Impact factor: 157.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.